Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Total 13F shares
-
6,729,352
-
Share change
-
+985,537
-
Total reported value
-
$52,695,053
-
Put/Call ratio
-
40%
-
Price per share
-
$7.83
-
Number of holders
-
65
-
Value change
-
+$7,761,585
-
Number of buys
-
30
-
Number of sells
-
22
Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q1 2024
As of 31 Mar 2024,
Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,729,352 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, Verition Fund Management LLC, MARSHALL WACE, LLP, Brandywine Global Investment Management, LLC, DIMENSIONAL FUND ADVISORS LP, and CITADEL ADVISORS LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.